U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C11H18N2O.2ClH
Molecular Weight 267.195
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRISOTINOL DIHYDROCHLORIDE

SMILES

Cl.Cl.CC(C)NC(C)CC1=CC=C(O)C=N1

InChI

InChIKey=WWKMQPRSOJYBNS-UHFFFAOYSA-N
InChI=1S/C11H18N2O.2ClH/c1-8(2)13-9(3)6-10-4-5-11(14)7-12-10;;/h4-5,7-9,13-14H,6H2,1-3H3;2*1H

HIDE SMILES / InChI

Description

Prisotinol is aminoalkyl-5-pyridinol patented by Ciba-Geigy A.-G. for treatment of angina pectoris. Prisotinol was studied in phase II clinical trials as a cardioprotective agent.

Originator

Ciba-Geigy A.-G.
15
Sources: JP 55149260; 2-​Aminoalkyl-​5-​pyridinols; Nov 20, 1980

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Urinary excretion of CGS 5,649 and its conjugated glucuronide and sulfate in man.
1991
Patents

Patents

20070122474
47
JP55149260
6

Sample Use Guides

In Vivo Use Guide
90, 200, or 600 mg
Route of Administration: Oral
Name Type Language
PRISOTINOL DIHYDROCHLORIDE
Common Name English
3-PYRIDINOL, 6-(2-((1-METHYLETHYL)AMINO)PROPYL)-, HYDROCHLORIDE (1:2)
Systematic Name English
3-PYRIDINOL, 6-(2-((1-METHYLETHYL)AMINO)PROPYL)-, DIHYDROCHLORIDE
Common Name English
Code System Code Type Description
PUBCHEM
20138281
Created by admin on Sat Dec 16 10:11:38 GMT 2023 , Edited by admin on Sat Dec 16 10:11:38 GMT 2023
PRIMARY PUBCHEM
FDA UNII
PPP3N7B22F
Created by admin on Sat Dec 16 10:11:38 GMT 2023 , Edited by admin on Sat Dec 16 10:11:38 GMT 2023
PRIMARY
CAS
78152-28-0
Created by admin on Sat Dec 16 10:11:38 GMT 2023 , Edited by admin on Sat Dec 16 10:11:38 GMT 2023
SUPERSEDED
CAS
76906-72-4
Created by admin on Sat Dec 16 10:11:38 GMT 2023 , Edited by admin on Sat Dec 16 10:11:38 GMT 2023
PRIMARY
PARENT (SALT/SOLVATE)
Structure of PRISOTINOL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966